In a huge victory for pharmaceutical giant Johnson & Johnson, a federal judge has dismissed all claims in a massive consumer fraud and RICO suit that accused the company of trying to hide widespread manufacturing and quality control problems that led to recalls of a slew of popular over-the-counter drugs including Tylenol, Motrin, Zyrtec, Benadryl, Rolaids and Mylanta.
The suit accused J&J and its subsidiary, McNeil Consumer Healthcare, of a conspiracy to conceal quality control issues and to dodge their duties to pay full refunds to consumers.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
